Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.5.2 and removed Revision: v3.5.0. This change does not affect the page content or study information.
    Difference
    0.1%
    Check dated 2026-04-16T10:48:34.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page. This appears to be a frontend metadata update with no changes to study content or eligibility.
    Difference
    0.1%
    Check dated 2026-03-18T17:53:37.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now shown on the page, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:39:57.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and deletion of government funding/outage notices (Revision: v3.4.1); these are site-wide maintenance updates and do not alter trial-specific content.
    Difference
    0.4%
    Check dated 2026-02-11T05:26:35.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Site-wide government funding notice was added and the page revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T04:52:24.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Minor UI/metadata updates were implemented, such as Show glossary and revision/version label changes (v3.4.0; No FEAR Act Data; Last Update Submitted that Met QC Criteria), with core study content unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:10:17.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.